WITHDRAWN: Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study (2023)
Attributed to:
MICA: Korea-UK PRISM consortium: Establishing Precision Medicine in severe asthma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.anai.2023.05.029
PubMed Identifier: 37268246
Publication URI: http://europepmc.org/abstract/MED/37268246
Type: Journal Article/Review
Parent Publication: Annals of Allergy, Asthma & Immunology
ISSN: 1081-1206